Need Help? Talk to an Expert +1 (408) 836-7136

Categorized Chronological Ownerhip by owner Transcripts Expert Interviews Holdings Your Highlights Financial Information Proxy/Share Holder Meeting Insider Transactions Beneficial Ownership/Institutional ownership Merger/Acquisition IPO/Public Offerings Securities-based Crowdfunding Regulation A Offering Foreign Private Issuers Mutual Funds and ETFs Variable Annuities Exhibits Delisitngs Deregister

Enliven Therapeutics, Inc.

CIK Ticker Name Accession Number Date Form
1672619 Enliven Therapeutics, Inc. 0000950170-24-126323 2024-11-13 16:10:10 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-24-163507 2024-06-18 17:12:01 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-24-149141 2024-05-29 16:06:31 8-K/A
1672619 Enliven Therapeutics, Inc. 0000950170-24-059573 2024-05-14 16:15:38 10-Q
1672619 Enliven Therapeutics, Inc. 0000950170-24-059544 2024-05-14 16:10:18 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-24-092522 2024-04-11 08:02:54 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-24-090821 2024-04-09 16:14:01 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-24-070839 2024-03-19 08:46:02 8-K
1672619 Enliven Therapeutics, Inc. 0000950170-24-031495 2024-03-14 16:15:39 10-K
1672619 Enliven Therapeutics, Inc. 0000950170-24-031482 2024-03-14 16:10:12 8-K
1672619 Enliven Therapeutics, Inc. 0000950170-23-062080 2023-11-09 16:15:39 10-Q
1672619 Enliven Therapeutics, Inc. 0000950170-23-062042 2023-11-09 16:10:11 8-K
1672619 Enliven Therapeutics, Inc. 0000950170-23-041349 2023-08-10 16:16:58 10-Q
1672619 Enliven Therapeutics, Inc. 0000950170-23-041322 2023-08-10 16:10:30 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-23-174006 2023-06-23 18:18:30 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-23-173796 2023-06-23 16:03:29 8-K
1672619 Enliven Therapeutics, Inc. 0000950170-23-021262 2023-05-11 16:16:19 10-Q
1672619 Enliven Therapeutics, Inc. 0001193125-23-142019 2023-05-11 16:11:07 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-23-075736 2023-03-21 16:06:54 8-K/A
1672619 Enliven Therapeutics, Inc. 0001193125-23-056303 2023-03-01 16:06:55 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-23-044902 2023-02-22 16:45:03 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-23-036052 2023-02-13 17:06:08 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-23-001729 2023-02-10 16:09:19 10-K
1672619 Enliven Therapeutics, Inc. 0001193125-22-298474 2022-12-05 16:31:03 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-22-285963 2022-11-15 19:56:02 8-K/A
1672619 Enliven Therapeutics, Inc. 0001193125-22-282630 2022-11-10 16:17:45 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-22-035098 2022-10-25 16:17:42 10-Q
1672619 Enliven Therapeutics, Inc. 0001193125-22-262375 2022-10-13 21:04:37 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-22-262210 2022-10-13 16:43:49 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-22-239422 2022-09-07 06:49:04 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-22-027795 2022-08-03 16:37:32 10-Q
1672619 Enliven Therapeutics, Inc. 0001564590-22-027108 2022-07-29 16:12:14 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-22-022471 2022-06-03 16:51:07 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-22-018458 2022-05-06 08:22:06 10-Q
1672619 Enliven Therapeutics, Inc. 0001564590-22-014494 2022-04-14 17:00:53 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-22-010216 2022-03-15 07:18:17 10-K
1672619 Enliven Therapeutics, Inc. 0001564590-22-010212 2022-03-15 07:07:13 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-21-055446 2021-11-09 07:24:09 10-Q
1672619 Enliven Therapeutics, Inc. 0001564590-21-055442 2021-11-09 07:13:14 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-21-051756 2021-10-25 17:12:06 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-21-041904 2021-08-06 07:18:28 10-Q
1672619 Enliven Therapeutics, Inc. 0001564590-21-041896 2021-08-06 07:06:47 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-21-214740 2021-07-14 09:19:59 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-21-214102 2021-07-13 16:07:19 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-21-035335 2021-06-30 16:10:26 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-21-032551 2021-06-11 07:00:29 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-21-026283 2021-05-11 07:20:40 10-Q
1672619 Enliven Therapeutics, Inc. 0001564590-21-026280 2021-05-11 07:09:40 8-K
1672619 Enliven Therapeutics, Inc. 0001193125-21-104184 2021-04-01 17:20:51 8-K
1672619 Enliven Therapeutics, Inc. 0001564590-21-011098 2021-03-05 07:26:01 10-K
Show More